Professor Paul Elkington is a clinician scientist with a subspecialty interest in tuberculosis. Paul leads the tuberculosis research group, studying an infection that continues to kill four thousand people every day. The group conducts cross-disciplinary research using bioengineering approaches to identify new diagnostic and therapeutic strategies to address a global epidemic that is second only to COVID-19, and has killed more humans than any other infection.